Straumann Holding AG
ISIN: CH1175448666 | Ticker: STMN | LEI: 529900UTFCXTI40NE790
Country: Switzerland
We are a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann conducts research, develops and manufactures dental implants, instruments, prosthetics, tissue and bone regeneration biomaterials for use in tooth replacement and restoration, or to prevent tooth loss. Technological advancements are changing dentistry fundamentally. Straumann offers a broad range of products and solutions for both conventional treatment and digital workflows including guided surgery, intra-oral scanning and CAD/CAM restorations.
We share your passion for quality and desire to achieve the best patient outcomes. Groundbreaking and evidence-based innovations are not the only reasons why you can enjoy peace of mind with us. Our highly skilled and motivated team has more than 60 years of experience in business partnering, training and education, and is dedicated to providing global support.
1954
Served areaWorldwide
Headcount9,000
HeadquartersPeter Merian-Weg 12, 4002 Basel – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 26.05.23 | None | Executive member | Sell | CHF 404,180.00 |
| 21.06.22 | None | Executive member | Sell | CHF 88,200.00 |
| 31.05.22 | None | Executive member | Sell | CHF 102,950.90 |
| 10.05.22 | None | Executive member | Sell | CHF 690,900.00 |
| 02.05.22 | None | Executive member | Buy | CHF 29,975.50 |
| 29.04.22 | None | Executive member | Buy | CHF 187,468.80 |
| 29.04.22 | None | Executive member | Buy | CHF 94,906.10 |
| 29.04.22 | None | Executive member | Buy | CHF 59,951.00 |
| 29.04.22 | None | Executive member | Buy | CHF 49,991.70 |
| 29.04.22 | None | Executive member | Buy | CHF 39,934.80 |
CH1175448666
LEI529900UTFCXTI40NE790
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.